Skip to main content
Premium Trial:

Request an Annual Quote

Rain Therapeutics, Tempus Partner to Identify Patients with MDM2-Amplified Tumors for Basket Trial

NEW YORK – Rain Therapeutics said on Thursday it has inked an agreement with Tempus, under which the Chicago-based firm will provide testing and patient matching services for Rain's Phase II tumor-agnostic basket trial for its investigational drug RAIN-32.

Tempus will provide centralized tumor testing and patient matching services through its Connect & TIME Trial Network platform. Specifically, it will evaluate patients with solid tumors for pre-specified MDM2 amplification levels and normal p53 status using its DNA- and RNA-based tumor sequencing tests, Tempus xT and Tempus xE, as well as conduct comprehensive tumor profiling to determine if they are eligible to receive Rain's MDM2 inhibitor RAIN-32 within the Phase II basket trial.

Earlier this week, Rain announced a similar partnership with Caris Life Sciences for this same study. Caris is providing whole-exome and -transcriptome sequencing services to help Rain identify patients eligible for the trial slated to begin in the second half of 2021.

The Newark, California-based company licensed RAIN-32, previously called milademetan, from Daiichi Sankyo in September. The firm is also planning two other trials of the drug, a Phase III study in MDM2-amplified liposarcoma and a Phase II trial in intimal sarcoma.

RAIN-32 showed activity in both MDM2-amplified liposarcoma and solid tumors in a Phase I trial presented last year. In patients with liposarcoma the disease control rate was 58.5 percent, and among patients with non-liposarcoma solid tumors the disease control rate was 32.4 percent.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.